Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription Articles published in Neurochem Res Retrieve available abstracts of 52 articles: HTML format

Single Articles

May 2026
1. WANG HL, Liu SY, Chiu CC, Yeh TH, et al
   Loss-of-Function (G603R) Lrp10 Fails to Downregulate mRNA of Pathologic alpha-Synuclein and Causes Neurodegeneration of Substantia Nigra Dopaminergic Cells in Parkinson's Disease Knockin Mice.
   Neurochem Res. 2026;51:162.
   PubMed     Abstract available
   
   
   April 2026
2. TEIXEIRA IMM, Duque BR, da Costa MDR, da Silva ME, et al
   Resveratrol-Loaded Polymeric Nanoparticles Protect Against Rotenone-Induced Parkinsonian-Like Cellular Damage In Vitro: Association with NRF2/HMOX-1 Expression Changes.
   Neurochem Res. 2026;51:138.
   PubMed     Abstract available
   
   
   
3. LIU Y, Li H, Bai J
   Mitochondrial Fission and Fusion Disorders and Autophagy Abnormalities in Parkinson's Disease.
   Neurochem Res. 2026;51:136.
   PubMed    
   
   
   March 2026
4. HASSOUNA I, Hassanein OH, El-Elaimy IA, Ibrahim HM, et al
   The Neuroameliorative Effects of Enzymatically Modified Isoquercitrin and Sodium R-lipoate on the Rotenone rat Model of Parkinson's Disease.
   Neurochem Res. 2026;51:120.
   PubMed     Abstract available
   
   
   
5. PEREZ-BARRON G, Sanchez-Gonzalez K, Cruz SL, Lopez-Rubalcava C, et al
   Antidepressant-like effect of hydroxytyrosol in a 1-methyl-4-phenylpyridinium model of Parkinson's disease in rats.
   Neurochem Res. 2026;51:99.
   PubMed    
   
   
   February 2026
6. ROUT M, Prusty SK, Singh V, Kispotta S, et al
   Targeting the Microbiota-Gut-Brain Axis: Bacillus coagulans Protects Against Rotenone-Induced Parkinson's Disease in Rats.
   Neurochem Res. 2026;51:86.
   PubMed     Abstract available
   
   
   
7. ANAYYAT U, Kiani MN, Mei X, Zhang F, et al
   Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T alpha-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways.
   Neurochem Res. 2026;51:77.
   PubMed     Abstract available
   
   
   January 2026
8. LIU C, Xu J, Mao S, Li P, et al
   Serum Aberrant Expression of miR-431-5p and Their Diagnostic Value in Parkinson's Disease.
   Neurochem Res. 2026;51:46.
   PubMed     Abstract available
   
   
   
9. HOUSHMAND F, Anjomshoa M, Najafi-Chaleshtori S, Mobini GR, et al
   Targeting Oxidative Stress and Apoptosis with Levothyroxine in Experimental Parkinson's Disease in Rats.
   Neurochem Res. 2026;51:38.
   PubMed    
   
   
   December 2025
10. DONG G, Fan L, Li C, Jiao Y, et al
    Schisanhenol Inhibits MPTP/MPP(+)-Induced Ferroptosis in Dopaminergic Neurons Via Nrf2/TrxR1/GPX4 Pathway against Parkinson's Disease.
    Neurochem Res. 2025;51:26.
    PubMed     Abstract available
    
    
    
11. ZHOU H, Fan H, Bian H, Zou Y, et al
    PRMT5 Aggravates Parkinson's Disease Progression Through the Inhibition of Neuronal Autophagy Through DKK1.
    Neurochem Res. 2025;51:12.
    PubMed     Abstract available
    
    
    November 2025
12. HAN B, Bai J
    Mitochondrial Calcium Channels and MAM Interaction in Calcium Homeostasis Dysregulation in Parkinson's Disease.
    Neurochem Res. 2025;50:361.
    PubMed     Abstract available
    
    
    
13. EVINOVA A, Okruhlica I, Racay P, Strnadel J, et al
    Intracellular Calcium Changes Correlate with Mitochondrial Dynamics After Differential Modulation of KATP Channels in a Cellular Model of Parkinson's Disease.
    Neurochem Res. 2025;50:345.
    PubMed     Abstract available
    
    
    October 2025
14. MANCA E, Corsi S, Fanni S, Noli B, et al
    Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.
    Neurochem Res. 2025;50:344.
    PubMed     Abstract available
    
    
    
15. PENSABENE D, Martella N, Scavo G, Bisesto E, et al
    p75NTR Modulation by LM11A-31 Counteracts Oxidative Stress and Cholesterol Dysmetabolism in a Rotenone-Induced Cell Model of Parkinson's Disease.
    Neurochem Res. 2025;50:315.
    PubMed     Abstract available
    
    
    
16. WALECHA V, Luthra PM
    The Mitochondrial-Astrocyte-Neuron Triad Hypothesis in Parkinson's Disease: A Toxic Feedback Loop of Metabolism, Aggregation, and Oxidative Stress.
    Neurochem Res. 2025;50:317.
    PubMed     Abstract available
    
    
    September 2025
17. WANKHEDE M, Rathod K, Aswar M, Aswar U, et al
    Stigmasterol Alleviates Levodopa-Induced Dyskinesia in 6-OHDA-Induced Parkinsonian Rats.
    Neurochem Res. 2025;50:304.
    PubMed     Abstract available
    
    
    
18. ZHU L, Lin L, Yang Z, Tang H, et al
    Sinomenine Modifies Parkinson's Disease Through Nrf2 Activation.
    Neurochem Res. 2025;50:302.
    PubMed     Abstract available
    
    
    
19. MEKHLOUF YE, Bouhaddou N, Dimaoui A, Ittorahou A, et al
    Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.
    Neurochem Res. 2025;50:294.
    PubMed     Abstract available
    
    
    August 2025
20. DESHPANDE V, Schick K, Mazumder P, Dutta AK, et al
    Biological Characterization of the Anti-ferroptotic Properties of a Novel Anti-Parkinsonian Iron (II) Selective Dopamine Agonist, D-583.
    Neurochem Res. 2025;50:264.
    PubMed     Abstract available
    
    
    June 2025
21. CHEN P, Yang J, Xu Y, Chen J, et al
    MicroRNA-361-3p Regulates Autophagy and Apoptotic Processes by Regulating PI3K/Akt Signaling in Parkinson's Disease.
    Neurochem Res. 2025;50:221.
    PubMed     Abstract available
    
    
    
22. ABD EL-KHALIK SR, AbuoHashish NA, Nasif E, Arakeep HM, et al
    Possible Mitigating Effect of Nobiletin on Rotenone-Induced Parkinsonism in Male Albino Rat Model: Targeting Bmal1/Nrf2 Mediated Ferroptosis and Restoring Mitochondrial Mitophagy.
    Neurochem Res. 2025;50:208.
    PubMed     Abstract available
    
    
    May 2025
23. NI Y, Hayat MA, Si Y, Guo T, et al
    Protective Effect of FABP5 Against 6-OHDA Induced Parkinson's Disease Via PPARgamma/SIRT1/PGC-1alpha Signaling Pathway.
    Neurochem Res. 2025;50:177.
    PubMed     Abstract available
    
    
    
24. CHINNAPPAN D, Krishnan M, Kuppamuthu A, Elangovan N, et al
    Developmental and Neuroprotective Effects of alpha-Terpineol in MPTP-Induced Parkinsonism in Zebrafish Larvae.
    Neurochem Res. 2025;50:158.
    PubMed     Abstract available
    
    
    April 2025
25. LEE C, Kim SS, Bae MA, Kim SH, et al
    Neuroprotective Activities of Sertraline, Tiagabine, and Bicifadine with Autophagy-Inducing Potentials in a 6-Hydroxidopamine-Treated Parkinson's Disease Cell Model.
    Neurochem Res. 2025;50:154.
    PubMed     Abstract available
    
    
    
26. SAHOO TA, Chand J, Kandy AT, Antony S, et al
    Unravelling the Proteinopathic Engagement of alpha-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.
    Neurochem Res. 2025;50:145.
    PubMed     Abstract available
    
    
    
27. ZHAO X, Cao R, Tian X, Liu P, et al
    OAB-14 Attenuated Glymphatic System Disorder, Neuroinflammation and Dyskinesia in Parkinson's Disease Model Mice Induced by Rotenone.
    Neurochem Res. 2025;50:142.
    PubMed     Abstract available
    
    
    November 2024
28. KHODIR SA, Sweed EM, Faried MA, Abo Elkhair DM, et al
    Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson's Disease in Rats: The Putative Role of the JAK/STAT Pathway.
    Neurochem Res. 2024;50:30.
    PubMed     Abstract available
    
    
    
29. CHEN Y, Gu Y, Cao C, Zheng Q, et al
    Exploring alpha-synuclein Interaction Partners and their Potential Clinical Implications for Parkinson's Disease.
    Neurochem Res. 2024;50:23.
    PubMed     Abstract available
    
    
    
30. GAO Y, Li S, Zhang S, Zhang Y, et al
    Atractylenolide-I Attenuates MPTP/MPP(+)?Mediated Oxidative Stress in Parkinson's Disease Through SIRT1/PGC?1alpha/Nrf2 Axis.
    Neurochem Res. 2024;50:18.
    PubMed     Abstract available
    
    
    August 2024
31. MUHAMMAD AJ, Al-Baqami FF, Alanazi FE, Alattar A, et al
    The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson's Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2.
    Neurochem Res. 2024 Aug 27. doi: 10.1007/s11064-024-04226.
    PubMed     Abstract available
    
    
    
32. AZIZIFAR N, Mohaddes G, Keyhanmanesh R, Athari SZ, et al
    Intranasal AdipoRon Mitigated Anxiety and Depression-Like Behaviors in 6-OHDA-Induced Parkinson 's Disease Rat Model: Going Beyond Motor Symptoms.
    Neurochem Res. 2024 Aug 3. doi: 10.1007/s11064-024-04223.
    PubMed     Abstract available
    
    
    
33. PEREZ VISNUK D, LeBlanc JG, de Moreno de LeBlanc A
    Neuroprotective Effects Exerted by a Combination of Selected Lactic Acid Bacteria in a Mouse Parkinsonism Model under Levodopa-Benserazide Treatment.
    Neurochem Res. 2024 Aug 1. doi: 10.1007/s11064-024-04217.
    PubMed     Abstract available
    
    
    May 2024
34. THIRUPATHI A, Marqueze LF, Outeiro TF, Radak Z, et al
    Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson's Disease.
    Neurochem Res. 2024 May 24. doi: 10.1007/s11064-024-04152.
    PubMed     Abstract available
    
    
    April 2024
35. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Correction: Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Apr 16. doi: 10.1007/s11064-024-04138.
    PubMed    
    
    
    
36. PERLIKOWSKA R, Silva J, Alves C, Susano P, et al
    Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2.
    Neurochem Res. 2024;49:895-918.
    PubMed     Abstract available
    
    
    March 2024
37. ZHAO J, Wang J, Zhao K, Zhang Y, et al
    Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson's Disease Mice Model.
    Neurochem Res. 2024 Mar 29. doi: 10.1007/s11064-024-04132.
    PubMed     Abstract available
    
    
    
38. KRYL'SKII ED, Razuvaev GA, Popova TN, Oleinik SA, et al
    6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis.
    Neurochem Res. 2024 Mar 19. doi: 10.1007/s11064-024-04125.
    PubMed     Abstract available
    
    
    
39. ESTEVES M, Cristovao AC, Vale A, Machado-Pereira M, et al
    MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
    Neurochem Res. 2024 Mar 7. doi: 10.1007/s11064-024-04130.
    PubMed     Abstract available
    
    
    February 2024
40. SHEN J, Chen S, Li X, Wu L, et al
    Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
    Neurochem Res. 2024 Feb 29. doi: 10.1007/s11064-024-04116.
    PubMed     Abstract available
    
    
    
41. XU F, Bian N, Li X
    SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
    Neurochem Res. 2024 Feb 21. doi: 10.1007/s11064-024-04106.
    PubMed     Abstract available
    
    
    
42. YANG J, Du C, Li Y, Liu R, et al
    Contrasting Iron Metabolism in Undifferentiated Versus Differentiated MO3.13 Oligodendrocytes via IL-1beta-Induced Iron Regulatory Protein 1.
    Neurochem Res. 2024;49:466-476.
    PubMed     Abstract available
    
    
    January 2024
43. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Jan 26. doi: 10.1007/s11064-024-04099.
    PubMed     Abstract available
    
    
    
44. DE ASSIS ALC, de Araujo Rodrigues P, de Morais SM, Rodrigues ALM, et al
    Byrsonima sericea Ethanol Extract Protected PC12 Cells from the Oxidative Stress and Apoptosis Induced by 6-Hydroxydopamine.
    Neurochem Res. 2024;49:234-244.
    PubMed     Abstract available
    
    
    
45. NISHIGUCHI H, Omura T, Sato A, Kitahiro Y, et al
    Luteolin Protects Against 6-Hydoroxydopamine-Induced Cell Death via an Upregulation of HRD1 and SEL1L.
    Neurochem Res. 2024;49:117-128.
    PubMed     Abstract available
    
    
    August 2023
46. HE ZQ, Huan PF, Wang L, He JC, et al
    Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-kappaB Signaling.
    Neurochem Res. 2023 Aug 10. doi: 10.1007/s11064-023-04004.
    PubMed     Abstract available
    
    
    
47. DA CRUZ GUEDES E, Erustes AG, Leao AHFF, Carneiro CA, et al
    Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or alpha-synuclein in Caenorhabditis elegans.
    Neurochem Res. 2023;48:2390-2405.
    PubMed     Abstract available
    
    
    July 2023
48. TIWARI S, Gupta P, Singh A, Chaturvedi S, et al
    Correction to: 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.
    Neurochem Res. 2023 Jul 5. doi: 10.1007/s11064-023-03975.
    PubMed    
    
    
    May 2023
49. SIDDIQUI T, Bhatt LK
    Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease.
    Neurochem Res. 2023 May 31:1-11. doi: 10.1007/s11064-023-03960.
    PubMed     Abstract available
    
    
    
50. SHARMA M, Sharma N, Khairnar A
    Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.
    Neurochem Res. 2023;48:1543-1560.
    PubMed     Abstract available
    
    
    March 2023
51. CHITHRA Y, Dey G, Ghose V, Chandramohan V, et al
    Mitochondrial Complex I Inhibition in Dopaminergic Neurons Causes Altered Protein Profile and Protein Oxidation: Implications for Parkinson's disease.
    Neurochem Res. 2023 Mar 25. doi: 10.1007/s11064-023-03907.
    PubMed     Abstract available
    
    
    
52. MORADI VASTEGANI S, Nasrolahi A, Ghaderi S, Belali R, et al
    Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies.
    Neurochem Res. 2023 Mar 21. doi: 10.1007/s11064-023-03904.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum